Busch F W, Ostendorf P, Schnaidt M, Wernet P, Waller H D
Dtsch Med Wochenschr. 1983 Aug 26;108(34):1284-7. doi: 10.1055/s-2008-1069736.
Four of five patients with idiopathic thrombocytopenic purpura (ITP) responded to high-dose immunoglobulin treatment with transitory rise in platelet count to normal values, while the fifth had only minimal improvement. In the individual case there was good correlation between serum-IgG concentration and platelet count, but an influence on platelet-associated IgG could not be demonstrated with certainty. Treatment with high-dose IgG is apparently particularly suitable for patients with ITP refractory to steroids or splenectomy, in whom bleeding complications or operative procedures make a transitory rise in platelet count desirable.